Add BrightSurf on Google Email

Mass General Brigham


The no surprises act has reduced patients’ out-of-pocket spending for medical care

A study by Mass General Brigham researchers found that the law significantly reduced out-of-pocket costs, but high burden medical spending remained unchanged. The findings suggest that additional policy efforts are needed to reduce healthcare-related financial burden, particularly among socioeconomically disadvantaged populations.

SourceMass General Brigham·JournalBMJ·TypeData/statistical analysis·DateAug 27, 2025

Researchers find link between history of traumatic brain injury and development of malignant brain tumor

A recent study by Mass General Brigham researchers found that adults with a history of moderate-to-severe traumatic brain injuries are at a higher risk of developing malignant brain tumors. The study evaluated data from over 75,000 people and discovered a significant association between TBI and increased tumor development.

SourceMass General Brigham·JournalJAMA Network Open·TypeData/statistical analysis·DateAug 25, 2025

Mediterranean diet may offset genetic risk of Alzheimer's

Researchers found that a Mediterranean-style diet helps reduce dementia risk and slow cognitive decline in people with high genetic risk for Alzheimer's disease. The diet has been shown to broadly influence key metabolic pathways, suggesting it could be an effective strategy for reducing the risk of cognitive decline.

SourceMass General Brigham·JournalNature Medicine·TypeObservational study·DateAug 25, 2025

Research Spotlight: Investigating the safety and efficacy of a hypoglossal nerve stimulator in young children with Down syndrome

Researchers found the treatment to be safe in all 29 children, with no serious adverse events. The device showed striking reductions in sleep apnea events, with over 95% of children achieving an OAHI reduction of more than 50%. This study provides hope for parents and offers implications for FDA approval and future trials.

SourceMass General Brigham·JournalInternational Journal of Pediatric Otorhinolaryngology·TypeObservational study·DateAug 5, 2025

Efforts underway to end race-based assessments of lung function

A multi-institutional team has proposed updates to national guidelines to remove race-based assessments from lung function testing. The authors highlight the need for a more equitable evaluation system, warning against overreliance on objective cutoff-based criteria. Several healthcare systems have already shifted to race-neutral refer...

SourceMass General Brigham·JournalNew England Journal of Medicine·DateJul 30, 2025

Clinical trial finds safe, effective treatment for children with severe post-Covid syndrome

Researchers at Mass General Brigham found larazotide effective in treating children with multisystem inflammatory syndrome in children (MIS-C), a rare but serious condition. The oral drug strengthened intestinal barriers to limit SARS-CoV-2 viral particle entry, resolving symptoms and improving recovery.

SourceMass General Brigham·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateJul 30, 2025

Research spotlight: Insights into palliative care for patients with cancer

A study of Medicare beneficiaries with poor-prognosis cancers found that outpatient palliative care visits doubled, mostly driven by advanced practice clinicians. However, a minority of decedents received any specialty palliative care, and access remained low for older adults, those with lower incomes, and those living in nonmetropolit...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 25, 2025

Study compares common type 2 diabetes drugs, finding higher cardiovascular risk for one medication

A recent study published in JAMA Network Open found that glipizide, a commonly used type 2 diabetes medication, is associated with a 13% increase in cardiovascular risk compared to dipeptidyl peptidase-4 (DPP-4) inhibitors. The study analyzed data from nearly 50,000 patients and found that glipizide was linked to higher rates of heart ...

SourceMass General Brigham·JournalJAMA Network Open·TypeObservational study·DateJul 24, 2025

Study finds large language models (LLMs) use stigmatizing language about individuals with alcohol and substance use disorders

A new study by Mass General Brigham found that over 35% of responses from large language models contained stigmatizing language related to alcohol- and substance use-related conditions. However, targeted prompts can reduce this language substantially. The authors recommend using patient-centered language to build trust with patients.

SourceMass General Brigham·JournalJournal of Addiction Medicine·TypeRandomized controlled/clinical trial·DateJul 24, 2025

Study identifies potential therapeutic strategy to prevent complications from sickle cell disease

A new study by Mass General Brigham investigators identified an ancient immune pathway that is activated in patients with acute chest syndrome (ACS) and serves as a key driver of the disease. Blocking this pathway with clinically approved drugs alleviated disease severity in preclinical models.

SourceMass General Brigham·JournalScience Translational Medicine·TypeExperimental study·DateJul 17, 2025

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

Researchers at Mass General Brigham found that targeted radiation was successful in treating patients with brain metastases, resulting in a lower neurological death rate and reduced need for subsequent whole brain radiation. This study supports personalized treatment approaches to maintain quality of life while managing brain metastases.

SourceMass General Brigham·JournalJournal of Clinical Oncology·TypeExperimental study·DateJul 11, 2025

New drug combination effective for T-cell lymphoma patients

Researchers at Mass General Brigham found a novel strategy to help patients control their disease, increasing eligibility for stem cell transplants. The combination of duvelisib and romidepsin was effective, tolerable, and safe for patients with relapsed/refractory peripheral and cutaneous T-cell lymphomas.

SourceMass General Brigham·JournalBlood Advances·TypeExperimental study·DateJul 1, 2025

More staff addressing mental health in schools buffers toll of growing up in disadvantaged communities

A new study from Mass General Brigham found that greater access to mental health staff in schools can help lower risk of mental health conditions among students growing up in disadvantaged neighborhoods. Higher school mental health staffing ratios counteracted the effects of neighborhood deprivation on anxiety and depressive symptoms, ...

SourceMass General Brigham·JournalJournal of the American Academy of Child & Adolescent Psychiatry·DateJun 25, 2025

New virtual reality training tool combats contamination of portable medical equipment

Researchers at Mass General Brigham have developed a virtual reality training tool to teach clinicians core concepts in infection control, including cleaning and disinfecting portable medical equipment. The pilot study found that 88.6% of participants reported an overall positive experience with the VR module.

SourceMass General Brigham·JournalInfection Control and Hospital Epidemiology·TypeExperimental study·DateJun 11, 2025

New drug combination increases overall survival in patients with PIK3CA-mutated advanced breast cancer

A new drug combination has shown significant improvements in overall survival for patients with advanced breast cancer who have the PIK3CA gene mutation. The treatment, which includes inavolisib, palbociclib, and fulvestrant, was found to extend median overall survival by 7 months compared to the placebo group.

SourceMass General Brigham·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 2, 2025

Modeling study predicts national fluoride ban would substantially increase children’s tooth decay and dental costs

A recent study found that eliminating fluoride from public water systems would substantially increase dental decay and related costs, particularly for publicly insured and uninsured children. The researchers estimated a 7.5 percentage point increase in tooth decay and $9.8 billion in additional dental care costs over five years.

SourceMass General Brigham·JournalJAMA Health Forum·TypeObservational study·DateMay 30, 2025

Timely initiation of statin therapy for diabetes shown to dramatically reduce risk of heart attack and stroke

A new study from Mass General Brigham found that patients with diabetes who started statin therapy immediately reduced the rate of heart attacks and strokes by one-third compared to those who delayed treatment. The study analyzed data from over 7,000 patients and used artificial intelligence to gather information.

SourceMass General Brigham·JournalJournal of the American Heart Association·TypeData/statistical analysis·DateMay 27, 2025